PFE and MRK · Invest & Retire Community

PFE and MRK

I checked prior discussions on MRK and PFE before posting. We’ve covered both Pfizer and Merck extensively since 2023 across various threads, and a new post in those would likely get buried or lack context.

MRK and PFE report earnings this week and next, respectively. Both stocks have been climbing steadily, mirroring gains in XLV (Health Care Select Sector SPDR Fund) and XBI (SPDR S&P Biotech ETF). It seems they’re finally attracting buyers.

Both companies face a common challenge: patent expirations. To address this, they’re actively acquiring other firms to bolster their pipelines.

I’m looking forward to their earnings reports. Thoughts on their outlook or recent moves?

8 comments